Terms: = Prostate cancer AND BTG1, P62324, 694, ENSG00000133639 AND Treatment
22 results:
1. Non-medical interventions to enhance return to work for people with cancer.
de Boer AG; Tamminga SJ; Boschman JS; Hoving JL
Cochrane Database Syst Rev; 2024 Mar; 3(3):CD007569. PubMed ID: 38441440
[TBL] [Abstract] [Full Text] [Related]
2. Routine practice data of three cancer entities: Comparison among cancer registry and health insurance data.
Lang LM; Behr C; Ludwig M; Walker J; Christian Lange H; Basedow F; Justenhoven C
Z Evid Fortbild Qual Gesundhwes; 2023 Apr; 177():65-72. PubMed ID: 36804770
[TBL] [Abstract] [Full Text] [Related]
3. Comparative proteomics reveals anticancer compounds from Lansium domesticum against NSCLC cells target mitochondrial processes.
Alvarez MR; De Juan F; Zhou Q; Dimzon IKD; Grijaldo SJ; Sunga S; Heralde F; Lebrilla CB; Completo GC; Nacario RC
Cell Biochem Funct; 2023 Mar; 41(2):166-176. PubMed ID: 36606472
[TBL] [Abstract] [Full Text] [Related]
4. A systematic review and meta-analysis on non-metastatic castration resistant prostate cancer: The radiation oncologist's perspective.
Ingrosso G; Bottero M; Becherini C; Caini S; Alì E; Lancia A; Ost P; Sanguineti G; Siva S; Zilli T; Francolini G; Bellavita R; Aristei C; Livi L; Detti B
Semin Oncol; 2022 Oct; 49(5):409-418. PubMed ID: 36192243
[TBL] [Abstract] [Full Text] [Related]
5. Comparative oncological outcomes after radical prostatectomy or external beam radiation therapy plus androgen deprivation therapy in men with clinical T3b prostate cancer.
Lee W; Lim B; Kyung YS; Kim CS
Int J Urol; 2022 May; 29(5):414-420. PubMed ID: 35133691
[TBL] [Abstract] [Full Text] [Related]
6. prostate cancer in Pennsylvania: The role of older age at diagnosis, aggressiveness, and environmental risk factors on treatment and mortality using data from the Pennsylvania cancer Registry.
Bluethmann SM; Wang M; Wasserman E; Chen C; Zaorsky NG; Hohl RJ; McDonald AC
Cancer Med; 2020 May; 9(10):3623-3633. PubMed ID: 32212232
[TBL] [Abstract] [Full Text] [Related]
7. The Role of the Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Radical prostatectomy: A Randomized Clinical Trial.
Baccaglini W; Pazeto CL; Corrêa Barros EA; Timóteo F; Monteiro L; Saad Rached RY; Navas A; Glina S
J Sex Med; 2020 Apr; 17(4):688-694. PubMed ID: 32007430
[TBL] [Abstract] [Full Text] [Related]
8. Taxane chemotherapy vs antiandrogen agents as first-line therapy for metastatic castration-resistant prostate cancer.
Sonpavde G; Huang A; Wang L; Baser O; Miao R
BJU Int; 2018 Jun; 121(6):871-879. PubMed ID: 29388324
[TBL] [Abstract] [Full Text] [Related]
9. A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer.
van Velthoven R; Aoun F; Marcelis Q; Albisinni S; Zanaty M; Lemort M; Peltier A; Limani K
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):79-83. PubMed ID: 26597660
[TBL] [Abstract] [Full Text] [Related]
10. prostate cancer patients' report on communication about endocrine therapy and its association with adherence.
Jung B; Stoll C; Feick G; Prott FJ; Zell J; Rudolph I; Huebner J
J Cancer Res Clin Oncol; 2016 Feb; 142(2):465-70. PubMed ID: 26494234
[TBL] [Abstract] [Full Text] [Related]
11. Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for prostate cancer.
Zumsteg ZS; Spratt DE; Romesser PB; Pei X; Zhang Z; Kollmeier M; McBride S; Yamada Y; Zelefsky MJ
J Urol; 2015 Dec; 194(6):1624-30. PubMed ID: 26165583
[TBL] [Abstract] [Full Text] [Related]
12. Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: implications for focal therapy.
Nguyen PL; Chen MH; Zhang Y; Tempany CM; Cormack RA; Beard CJ; Hurwitz MD; Suh WW; D'Amico AV
J Urol; 2012 Oct; 188(4):1151-6. PubMed ID: 22901567
[TBL] [Abstract] [Full Text] [Related]
13. Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.
Abdollah F; Sun M; Schmitges J; Thuret R; Bianchi M; Shariat SF; Briganti A; Jeldres C; Perrotte P; Montorsi F; Karakiewicz PI
J Urol; 2012 Jul; 188(1):73-83. PubMed ID: 22578732
[TBL] [Abstract] [Full Text] [Related]
14. Increased risk of cancer among gout patients: a nationwide population study.
Kuo CF; Luo SF; See LC; Chou IJ; Fang YF; Yu KH
Joint Bone Spine; 2012 Jul; 79(4):375-8. PubMed ID: 22088929
[TBL] [Abstract] [Full Text] [Related]
15. cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort.
Abdollah F; Sun M; Schmitges J; Tian Z; Jeldres C; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
Eur Urol; 2011 Nov; 60(5):920-30. PubMed ID: 21741762
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of ACINUS, caspase-3, and TUNEL as apoptotic markers in determination of tumor growth rates of clinically localized prostate cancer using image analysis.
Singh SS; Mehedint DC; Ford OH; Jeyaraj DA; Pop EA; Maygarden SJ; Ivanova A; Chandrasekhar R; Wilding GE; Mohler JL
Prostate; 2009 Nov; 69(15):1603-1610. PubMed ID: 19644955
[TBL] [Abstract] [Full Text] [Related]
17. Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism.
Wang Y; Shao C; Shi CH; Zhang L; Yue HH; Wang PF; Yang B; Zhang YT; Liu F; Qin WJ; Wang H; Shao GX
Asian J Androl; 2005 Dec; 7(4):375-80. PubMed ID: 16281084
[TBL] [Abstract] [Full Text] [Related]
18. Radical external beam radiotherapy for clinically localized prostate cancer in Japan: changing trends in the patterns of care process survey between 1996-1998 and 1999-2001.
Ogawa K; Nakamura K; Onishi H; Sasaki T; Koizumi M; Shioyama Y; Komiyama T; Miyabe Y; Teshima T;
Anticancer Res; 2005; 25(5):3507-11. PubMed ID: 16101170
[TBL] [Abstract] [Full Text] [Related]
19. Single-agent chemotherapy with docetaxel significantly reduces PSA levels in patients with high-grade localized prostate cancers.
Berger AP; Niescher M; Fischer-Colbrie R; Pelzer A; Bartsch G; Horninger W
Urol Int; 2004; 73(2):110-2. PubMed ID: 15331892
[TBL] [Abstract] [Full Text] [Related]
20. Radical external beam radiotherapy for prostate cancer in Japan: preliminary results of the changing trends in the Patterns of Care process survey between 1996-1998 and 1999-2001.
Ogawa K; Nakamura K; Sasaki T; Yamamoto T; Koizumi M; Inoue T; Teshima T;
Jpn J Clin Oncol; 2004 Mar; 34(3):131-6. PubMed ID: 15078908
[TBL] [Abstract] [Full Text] [Related]
[Next]
